Javascript must be enabled to continue!
Complete Response Evaluation of Locally Advanced Rectal Cancer to Neoadjuvant Chemoradiotherapy Using Textural Features Obtained from T2 Weighted Imaging and ADC Maps
View through CrossRef
Background:
The prediction of pathological responses for locally advanced rectal cancer
using magnetic resonance imaging (MRI) after neoadjuvant chemoradiotherapy (CRT) is a challenging
task for radiologists, as residual tumor cells can be mistaken for fibrosis. Texture analysis of MR images
has been proposed to understand the underlying pathology.
Objective:
This study aimed to assess the responses of lesions to CRT in patients with locally advanced
rectal cancer using the first-order textural features of MRI T2-weighted imaging (T2-WI) and apparent
diffusion coefficient (ADC) maps.
Methods:
Forty-four patients with locally advanced rectal cancer (median age: 57 years) who underwent
MRI before and after CRT were enrolled in this retrospective study. The first-order textural parameters
of tumors on T2-WI and ADC maps were extracted. The textural features of lesions in pathologic
complete responders were compared to partial responders using Student’s t- or Mann–Whitney U
tests. A comparison of textural features before and after CRT for each group was performed using the
Wilcoxon rank sum test. Receiver operating characteristic curves were calculated to detect the diagnostic
performance of the ADC.
Results:
Of the 44 patients evaluated, 22 (50%) were placed in a partial response group and 50% were
placed in a complete response group. The ADC changes of the complete responders were statistically
more significant than those of the partial responders (P = 0.002). Pathologic total response was predicted
with an ADC cut-off of 1310 x 10-6 mm2/s, with a sensitivity of 72%, a specificity of 77%, and
an accuracy of 78.1% after neoadjuvant CRT. The skewness of the T2-WI before and after neoadjuvant
CRT showed a significant difference in the complete response group compared to the partial response
group (P = 0.001 for complete responders vs. P = 0.482 for partial responders). Also, relative T2-WI
signal intensity in the complete response group was statistically lower than that of the partial response
group after neoadjuvant CRT (P = 0.006).
Conclusion:
As a result of the conversion of tumor cells to fibrosis, the skewness of the T2-WI before
and after neoadjuvant CRT was statistically different in the complete response group compared to the
partial response group, and the complete response group showed statistically lower relative T2-WI
signal intensity than the partial response group after neoadjuvant CRT. Additionally, the ADC cut-off
value of 1310 × 10-6 mm2/s could be used as a marker for a complete response along with absolute
ADC value changes within this dataset.
Title: Complete Response Evaluation of Locally Advanced Rectal Cancer to
Neoadjuvant Chemoradiotherapy Using Textural Features Obtained from
T2 Weighted Imaging and ADC Maps
Description:
Background:
The prediction of pathological responses for locally advanced rectal cancer
using magnetic resonance imaging (MRI) after neoadjuvant chemoradiotherapy (CRT) is a challenging
task for radiologists, as residual tumor cells can be mistaken for fibrosis.
Texture analysis of MR images
has been proposed to understand the underlying pathology.
Objective:
This study aimed to assess the responses of lesions to CRT in patients with locally advanced
rectal cancer using the first-order textural features of MRI T2-weighted imaging (T2-WI) and apparent
diffusion coefficient (ADC) maps.
Methods:
Forty-four patients with locally advanced rectal cancer (median age: 57 years) who underwent
MRI before and after CRT were enrolled in this retrospective study.
The first-order textural parameters
of tumors on T2-WI and ADC maps were extracted.
The textural features of lesions in pathologic
complete responders were compared to partial responders using Student’s t- or Mann–Whitney U
tests.
A comparison of textural features before and after CRT for each group was performed using the
Wilcoxon rank sum test.
Receiver operating characteristic curves were calculated to detect the diagnostic
performance of the ADC.
Results:
Of the 44 patients evaluated, 22 (50%) were placed in a partial response group and 50% were
placed in a complete response group.
The ADC changes of the complete responders were statistically
more significant than those of the partial responders (P = 0.
002).
Pathologic total response was predicted
with an ADC cut-off of 1310 x 10-6 mm2/s, with a sensitivity of 72%, a specificity of 77%, and
an accuracy of 78.
1% after neoadjuvant CRT.
The skewness of the T2-WI before and after neoadjuvant
CRT showed a significant difference in the complete response group compared to the partial response
group (P = 0.
001 for complete responders vs.
P = 0.
482 for partial responders).
Also, relative T2-WI
signal intensity in the complete response group was statistically lower than that of the partial response
group after neoadjuvant CRT (P = 0.
006).
Conclusion:
As a result of the conversion of tumor cells to fibrosis, the skewness of the T2-WI before
and after neoadjuvant CRT was statistically different in the complete response group compared to the
partial response group, and the complete response group showed statistically lower relative T2-WI
signal intensity than the partial response group after neoadjuvant CRT.
Additionally, the ADC cut-off
value of 1310 × 10-6 mm2/s could be used as a marker for a complete response along with absolute
ADC value changes within this dataset.
Related Results
Sequelae after multimodal treatment of rectal cancer
Sequelae after multimodal treatment of rectal cancer
<p dir="ltr">In recent decades, rectal cancer treatment has shifted from traditional surgical resection to include additional modalities such as radiotherapy and chemotherapy...
Sequelae after multimodal treatment of rectal cancer
Sequelae after multimodal treatment of rectal cancer
<p dir="ltr">In recent decades, rectal cancer treatment has shifted from traditional surgical resection to include additional modalities such as radiotherapy and chemotherapy...
Neoadjuvant Immunotherapy and Non–Small Cell Lung Cancer
Neoadjuvant Immunotherapy and Non–Small Cell Lung Cancer
Objectives:
To systematically evaluate the effectiveness and safety of neoadjuvant immunotherapy for patients with non–small cell lung cancer (NSCLC).
...
Assessment of results of thoraco - laparoscopic esophagectomy
in patients receiving neoadjuvant chemoradiotherapy for esophageal cancers
Assessment of results of thoraco - laparoscopic esophagectomy
in patients receiving neoadjuvant chemoradiotherapy for esophageal cancers
Abstract
Introduction: Laparoscopic esophagectomy plays an important role in esophageal cancer. In recent years, the treatment of esophageal cancer is multidisciplinary, especially...
Outcome of neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in non-metastatic locally advanced non-small cell lung cancer – A prospective and randomized study
Outcome of neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in non-metastatic locally advanced non-small cell lung cancer – A prospective and randomized study
Background: Sequential chemoradiotherapy and concurrent chemoradiotherapy are two treatment options for locally advanced non-small cell lung cancer (NSCLC). Still there is limited ...
Impact on CD4+ CD25High-CD127low regulatory T (Treg) cells of neoadjuvant therapy for rectal cancer patients
Impact on CD4+ CD25High-CD127low regulatory T (Treg) cells of neoadjuvant therapy for rectal cancer patients
ABSTRACT
Background:
The efficacy of neoadjuvant therapy for rectal cancer has not been assessed.
Objective:
...
Pathologic response after neoadjuvant chemoradiotherapy in Sudanese patients with locally advanced rectal adenocarcinoma
Pathologic response after neoadjuvant chemoradiotherapy in Sudanese patients with locally advanced rectal adenocarcinoma
Background: Locally advanced rectal cancer can be down staged by neoadjuvant therapy and the resultant tumor response can be quantified histologically.Objective: This study aimed t...
Value of ypTNM stage in patients with rectal cancer
Value of ypTNM stage in patients with rectal cancer
Abstract
Purpose:
In the current NCCN guidelines, the prognosis and adjuvant chemotherapy regimen of patients who underwent neo...

